Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Short Interest Update

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) was the target of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 87,300 shares, a drop of 52.5% from the October 31st total of 183,700 shares. Currently, 1.2% of the company’s shares are sold short. Based on an average trading volume of 3,550,000 shares, the short-interest ratio is presently 0.0 days.

Catheter Precision Stock Performance

Shares of NYSEAMERICAN VTAK opened at $0.42 on Thursday. Catheter Precision has a 1 year low of $0.31 and a 1 year high of $8.40. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.65 and a current ratio of 0.66.

About Catheter Precision

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.